why choose us

First received: May 01, 2023

Clinical Trial: Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Lymphoid Leukemia

Study Type: OBSERVATIONAL


Official Title: Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

Brief Summary: To use a consistent and standardized platform to retrospectively and prospectively study children and young adults with B cell malignancies receiving Immunotherapy, blinatumomab and/or inotuzumab ozogamicin.

Read more